CEBP Infection and Cancer: Biology, Therapeutics, and Prevention Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gann, P. H.
Right arrow Articles by Chatterton, R. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gann, P. H.
Right arrow Articles by Chatterton, R. T., Jr.
Cancer Epidemiology Biomarkers & Prevention Vol. 10, 59-64, January 2001
© 2001 American Association for Cancer Research

Saliva as a Medium for Investigating Intra- and Interindividual Differences in Sex Hormone Levels in Premenopausal Women1

Peter H. Gann2, Susan Giovanazzi, Linda Van Horn, Amy Branning and Robert T. Chatterton, Jr.

Department of Preventive Medicine [P. H. G., S. G., L. V. H., A. B.], Robert H. Lurie Comprehensive Cancer Center [P. H. G., L. V. H., R. T. C.], and Department of Obstetrics and Gynecology [R. T. C.], Northwestern University Medical School, Chicago, Illinois 60611

Repeated measurement of ovarian steroids in saliva could provide an advantage in studies estimating long-term sex steroid exposure in premenopausal women, by reducing the measurement error associated with collection of serum or urine samples. We previously reported on characteristics of ultrasensitive RIAs adapted for extraction-free measurement of estradiol (E2) and progesterone (PG) in saliva. The purpose of the present study was to evaluate the consistency of E2 and PG levels in saliva in the same women across menstrual cycles, and to compare this with the variation observed between women. We also evaluated the effect of altering the number of consecutive daily samples considered and the method for locating a particular cycle day in relation to ovulation (day 0). Study participants included 12 healthy women who provided daily saliva samples for two consecutive, ovulatory menstrual cycles. A single midluteal serum sample was collected 7–8 days after detection of a luteinizing hormone (LH) peak in urine. We plotted individual cycle profiles and computed intraclass correlation coefficients (ICC) for various definitions of peak and cumulative daily hormone level. For peak PG, determined as the maximal running 3-day mean, ICC was 0.68. For cumulative PG, based on 8 consecutive cycle days (+2 to +9), ICCs were 0.72–0.76 when reverse dating LH peak or rise in salivary PG determined day 0. For E2, ICCs ranged from 0.74 to 0.79 by various dating methods for the 5 preovulatory days (-4–0), and from 0.85 to 0.92 for the 15 days about the center of the cycle (-6 to +8). With exclusion of just the first 5 days of the cycle, the ICC for E2 was 0.91. For both E2 and PG, selection of 5 or 7 days for the estimation of the midluteal mean level provided separation of within and between subject variance that was comparable with a LH-timed serum sample. These results indicate that daily saliva samples can be combined to clarify the interindividual differences in E2 and PG levels in premenopausal women, and that these interindividual differences may be greater than previously imagined.




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. J. Sherman and L. LeResche
Does experimental pain response vary across the menstrual cycle? A methodological review
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R245 - R256.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. H. Gann, A. S. Geiger, I. B. Helenowski, E. F. Vonesh, and R. T. Chatterton
Estrogen and Progesterone Levels in Nipple Aspirate Fluid of Healthy Premenopausal Women: Relationship to Steroid Precursors and Response Proteins
Cancer Epidemiol. Biomarkers Prev., January 1, 2006; 15(1): 39 - 44.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
R. T Chatterton Jr, E. T Mateo, N. Hou, A. W Rademaker, S. Acharya, V C. Jordan, and M. Morrow
Characteristics of salivary profiles of oestradiol and progesterone in premenopausal women
J. Endocrinol., July 1, 2005; 186(1): 77 - 84.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. T. Chatterton Jr., A. S. Geiger, S. A. Khan, I. B. Helenowski, B. D. Jovanovic, and P. H. Gann
Variation in Estradiol, Estradiol Precursors, and Estrogen-related Products in Nipple Aspirate Fluid from Normal Premenopausal Women
Cancer Epidemiol. Biomarkers Prev., June 1, 2004; 13(6): 928 - 935.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
N. Ahmad, T. M. Pollard, and N. Unwin
The Optimal Timing of Blood Collection during the Menstrual Cycle for the Assessment of Endogenous Sex Hormones: Can Interindividual Differences in Levels over the Whole Cycle Be Assessed on a Single Day?
Cancer Epidemiol. Biomarkers Prev., January 1, 2002; 11(1): 147 - 151.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.